Company intelligence
aMoon Fund
Accelerating Cure
About aMoon Fund
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare. Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives. We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality. Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.
Verified activity
Signals from aMoon Fund
2 published signals
Strategy & Corporate Development
aMoon Fund pushed forward with the mandate to make the INBI model operational in 12 months.
Reported by Samuel Moed
Partnerships
aMoon Fund applauded 15 founding partners who enabled the INBI model to create a national network of academic research and researchers.
Reported by Samuel Moed